Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Apr;64(4):1473–1476. doi: 10.1128/iai.64.4.1473-1476.1996

Oral immunization with a recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence inhibition activity.

D E Beving 1, C J Soong 1, J I Ravdin 1
PMCID: PMC173947  PMID: 8606122

Abstract

The LC3-encoded 52-kDa recombinant protein includes amino acids 758 to 1134 of the 170-kDa subunit of the galactose-inhibitable lectin. Oral immunization of BALB/c mice with the LC3-encoded protein and cholera holotoxin induced an intestinal secretory immunoglobulin A (IgA) response (P < 0.01 compared with the control). There was a negative correlation (P = 0.001) between intestinal anti-LC3 IgA and serum IgA and IgG antibody responses. Intestinal secretions from immunized mice completely inhibited the galactose-specific adherence of axenic trophozoites ot Chinese hamster ovary cells (P < 0.01).

Full Text

The Full Text of this article is available as a PDF (233.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aceti A., Pennica A., Celestino D., Caferro M., Leri O., Catalini N., Sebastiani A. Salivary IgA antibody detection in invasive amebiasis and in asymptomatic infection. J Infect Dis. 1991 Sep;164(3):613–615. doi: 10.1093/infdis/164.3.613. [DOI] [PubMed] [Google Scholar]
  2. Carrero J. C., Díaz M. Y., Viveros M., Espinoza B., Acosta E., Ortiz-Ortiz L. Human secretory immunoglobulin A anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells. Infect Immun. 1994 Feb;62(2):764–767. doi: 10.1128/iai.62.2.764-767.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chadee K., Johnson M. L., Orozco E., Petri W. A., Jr, Ravdin J. I. Binding and internalization of rat colonic mucins by the galactose/N-acetyl-D-galactosamine adherence lectin of Entamoeba histolytica. J Infect Dis. 1988 Aug;158(2):398–406. doi: 10.1093/infdis/158.2.398. [DOI] [PubMed] [Google Scholar]
  4. Chadee K., Petri W. A., Jr, Innes D. J., Ravdin J. I. Rat and human colonic mucins bind to and inhibit adherence lectin of Entamoeba histolytica. J Clin Invest. 1987 Nov;80(5):1245–1254. doi: 10.1172/JCI113199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Diamond L. S., Harlow D. R., Cunnick C. C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–432. doi: 10.1016/0035-9203(78)90144-x. [DOI] [PubMed] [Google Scholar]
  6. Grundy M. S., Cartwright-Taylor L., Lundin L., Thors C., Huldt G. Antibodies against Entamoeba histolytica in human milk and serum in Kenya. J Clin Microbiol. 1983 May;17(5):753–758. doi: 10.1128/jcm.17.5.753-758.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holmgren J., Czerkinsky C., Lycke N., Svennerholm A. M. Mucosal immunity: implications for vaccine development. Immunobiology. 1992 Feb;184(2-3):157–179. doi: 10.1016/S0171-2985(11)80473-0. [DOI] [PubMed] [Google Scholar]
  8. Holmgren J., Czerkinsky C., Lycke N., Svennerholm A. M. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Am J Trop Med Hyg. 1994;50(5 Suppl):42–54. [PubMed] [Google Scholar]
  9. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 1993 Sep;11(12):1179–1184. doi: 10.1016/0264-410x(93)90039-z. [DOI] [PubMed] [Google Scholar]
  10. Islam A., Stoll B. J., Ljungstrom I., Biswas J., Nazrul H., Huldt G. The prevalence of Entamoeba histolytica in lactating women and in their infants in Bangladesh. Trans R Soc Trop Med Hyg. 1988;82(1):99–103. doi: 10.1016/0035-9203(88)90276-3. [DOI] [PubMed] [Google Scholar]
  11. Jertborn M., Svennerholm A. M., Holmgren J. Five-year immunologic memory in Swedish volunteers after oral cholera vaccination. J Infect Dis. 1988 Feb;157(2):374–377. doi: 10.1093/infdis/157.2.374. [DOI] [PubMed] [Google Scholar]
  12. Kelsall B. L., Jackson T. G., Gathiram V., Salig S. B., Vaithilingum M., Pearson R. D., Ravdin J. I. Secretory immunoglobulin A antibodies to the galactose-inhibitable adherence protein in the saliva of patients with amebic liver disease. Am J Trop Med Hyg. 1994 Oct;51(4):454–459. [PubMed] [Google Scholar]
  13. Kelsall B. L., Ravdin J. I. Immunization of rats with the 260-kilodalton Entamoeba histolytica galactose-inhibitable lectin elicits an intestinal secretory immunoglobulin A response that has in vitro adherence-inhibitory activity. Infect Immun. 1995 Feb;63(2):686–689. doi: 10.1128/iai.63.2.686-689.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Keren D. F. Antigen processing in the mucosal immune system. Semin Immunol. 1992 Aug;4(4):217–226. [PubMed] [Google Scholar]
  15. Lewis D. J., Castello-Branco L. R., Novotny P., Dougan G., Poulton T. A., Griffin G. E. Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit. Vaccine. 1993;11(2):119–121. doi: 10.1016/0264-410x(93)90005-i. [DOI] [PubMed] [Google Scholar]
  16. Lycke N., Holmgren J. Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin. Infect Immun. 1989 Apr;57(4):1137–1141. doi: 10.1128/iai.57.4.1137-1141.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lycke N., Holmgren J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology. 1986 Oct;59(2):301–308. [PMC free article] [PubMed] [Google Scholar]
  18. McGhee J. R., Mestecky J., Dertzbaugh M. T., Eldridge J. H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 1992;10(2):75–88. doi: 10.1016/0264-410x(92)90021-b. [DOI] [PubMed] [Google Scholar]
  19. Petri W. A., Jr, Smith R. D., Schlesinger P. H., Murphy C. F., Ravdin J. I. Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica. J Clin Invest. 1987 Nov;80(5):1238–1244. doi: 10.1172/JCI113198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ravdin J. I., Guerrant R. L. Role of adherence in cytopathogenic mechanisms of Entamoeba histolytica. Study with mammalian tissue culture cells and human erythrocytes. J Clin Invest. 1981 Nov;68(5):1305–1313. doi: 10.1172/JCI110377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Revillard J. P., Cozon G., Czerkinsky C. Oral administration of immunomodulators and the mucosal immune system. Dev Biol Stand. 1992;77:31–37. [PubMed] [Google Scholar]
  22. Soong C. J., Kain K. C., Abd-Alla M., Jackson T. F., Ravdin J. I. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. J Infect Dis. 1995 Mar;171(3):645–651. doi: 10.1093/infdis/171.3.645. [DOI] [PubMed] [Google Scholar]
  23. Zhang T., Li E., Stanley S. L., Jr Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response. Infect Immun. 1995 Apr;63(4):1349–1355. doi: 10.1128/iai.63.4.1349-1355.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. del Muro R., Acosta E., Merino E., Glender W., Ortiz-Ortiz L. Diagnosis of intestinal amebiasis using salivary IgA antibody detection. J Infect Dis. 1990 Dec;162(6):1360–1364. doi: 10.1093/infdis/162.6.1360. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES